Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology May 1;37(13):1102-1110; Mar 12:JCO1801100. doi: 10.1200/JCO.18.01100. [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Melanoma and Multiple sites
- PMID
- PMID30860949
- PMC
- PMC6494357
- Study Number(s)
- S0438
RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis
- Journal / Conference
- Clinical Cancer Research Aug 1;25(15):4592-4602; Mar 1. pii: clincanres.1538.2018. doi: 10.1158/1078-0432.CCR-18-1538. [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Lung
- PMID
- PMID30824587
- PMC
- PMC6679805
- Study Number(s)
- S1400
Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes. [Review]
- Journal / Conference
- Cancer Treatment Reviews Jan;72:15-27
- Year
- 2019
- Research Committee(s)
- Lung
- PMID
- PMID30445271
- Study Number(s)
- S0342, S0536, S0819
EGFR-directed monoclonal antibodies in combination with chemotherapy for treatment of non-small-cell lung cancer: an updated review of clinical trials and new perspectives in biomarkers analysis [Review]
- Journal / Conference
- Journal of Geriatric Oncology Feb 20. pii: S1879-4068(18)30197-8. doi: 10.1016/j.jgo.2019.02.007. [Epub ahead of print]
- Year
- 2019
- Research Committee(s)
- Lung
- PMID
- PMID30797707
- Study Number(s)
- S0023, S0027, S0536, SWOG-9019, SWOG-9308, SWOG-9429, SWOG-9504, SWOG-9509, S9712
Clinical prognostic model for older patients with advanced non-small cell lung cancer
- Journal / Conference
- New England Journal of Medicine Mar 28;380(13):1226-1234
- Year
- 2019
- Research Committee(s)
- Breast
- PMID
- PMID30917258
- PMC
- PMC6885383
- Study Number(s)
- S0226
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer
- Journal / Conference
- Journal for ImmunoTherapy of Cancer Apr 10;7(1):88
- Year
- 2019
- Research Committee(s)
- Breast
- PMID
- PMID30967156
- PMC
- PMC6457012
- Study Number(s)
- S0800
Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial
- Journal / Conference
- Journal of Clinical Oncology Jul 20;37(21):1790-1799
- Year
- 2019
- Research Committee(s)
- Lymphoma
- PMID
- PMID30939090
- PMC
- PMC6774813
Dose-Adjusted EPOCH-R Compared with R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase 3 Intergroup Trial Alliance/CALGB 50303
- Journal / Conference
- J Clin Oncol 37, 2019 (suppl; abstr 552); ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), poster session
- Year
- 2019
- Research Committee(s)
- Breast
- Study Number(s)
- S0307
Factors associated with osteonecrosis of the jaw in women with breast cancer receiving highdose bisphosphonates to prevent breast cancer metastases as part of the SWOG 0307 trial
- Journal / Conference
- J Clin Oncol 37 (suppl; abstr 11502);ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), oral
- Year
- 2019
- Research Committee(s)
- Symptom Management and Survivorship
- Study Number(s)
- S0702
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases: SWOG S0702, NCT00874211
- Journal / Conference
- J Clin Oncol 37, 2019 (suppl; abstr 552); ASCO Annual Meeting (May 31-June 4, 2019, Chicago, IL), poster session
- Year
- 2019
- Research Committee(s)
- Lung
- Study Number(s)
- S1206 (8811)